Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study.
暂无分享,去创建一个
H. Palevsky | D. Badesch | A. Frost | V. McLaughlin | V. Tapson | K. Chin | L. Rubin | S. Kawut | I. Robbins | N. Kim | J. Lemarié | W. Benton | F. Bodin